1-20 of 31
Liping Su
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes and Clinical Practice Among Patient with Chronic Lymphocytic Leukemia Treated with Ibrutinib in China: A Real-World Experience

Shenmiao Yang, Ru Feng, Xutao Guo, Zhenling Li, Qianqian Ju, Yujun Dong, Bingjie Wang, Yu Zhao, Liang Wang, Wanling Sun, Fang Fang, Liru Wang, Liping Su, Xiaojun Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7819.
https://doi.org/10.1182/blood-2024-210572
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with Azacitidine and Chidamide Can be an Effective Chemotherapy Regimen for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Yanli Wang, Li Lang, Li Ma, Jingrong Wang, Shaohua Wu, Min Bai, Xuliang Shen, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6514.
https://doi.org/10.1182/blood-2024-205043
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with R-GDP Regimen in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Single-Arm Study

Li Ma, Jin Zhao, Jingrong Wang, Meijing Zheng, Xiaolian Wen, Junyuan Lang, Bin Yang, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6506.
https://doi.org/10.1182/blood-2024-205306
Published: 2024
Journal Articles

R-Cmop in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter, Prospective Study

Xiaolian Wen, Lieyang Wang, Li Ma, Jingrong Wang, Shaohua Wu, Zhiqiang Zhao, Yalan Wang, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6487.
https://doi.org/10.1182/blood-2024-207588
Published: 2024
Journal Articles

Circulating Tumour DNA Measurements As an Early Prognostic Indicator for Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Pola-R-CHP Regimen

Xiaolian Wen, Liping Su, Tao Guan, Jie Liu, Xuliang Shen
Journal: Blood
Blood (2024) 144 (Supplement 1): 6186.
https://doi.org/10.1182/blood-2024-206716
Published: 2024
Journal Articles

Study on the Bone Marrow Plasma Cell Percentage in Predicting Survival in Newly Diagnosed Multiple Myeloma

Tao Guan, Meijing Zheng, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6984.
https://doi.org/10.1182/blood-2024-206521
Published: 2024
Journal Articles

Identification of Piwi-Interacting RNA-32260 As a Prognostic Marker for Diffuse Large B-Cell Lymphoma

Min Zhang, Tao Guan, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6232.
https://doi.org/10.1182/blood-2024-209417
Published: 2024
Journal Articles

Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)

Jie Jin, Liling Zhang, Liqun Zou, Zengjun Li, Huijing Wu, Keshu Zhou, Lihua Qiu, Liping Su, Kaiyang Ding, Hui Zhou, Li Yu, Fei Li, Qing Xiao, Wenyu Li, Lie Lin, Erhua Wang, Lijia Chen, Qingqing Cai
Journal: Blood
Blood (2024) 144 (Supplement 1): 6368.
https://doi.org/10.1182/blood-2024-211891
Published: 2024
Journal Articles

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Lu Zhang, Qinhua Liu, Hui Zhou, Huilai Zhang, Yujun Dong, Xiaobo Wang, Luqun Wang, Liping Su, Xiaojing Yan, Yan Li, Mingzhi Zhang, Kaiyang Ding, Hui-Han Wang, Hongling Peng, Liye Zhong, Lin Yang, Lintao Bi, Da Gao, Guangxun Gao, Liang Huang, Chunyan Sun, Jia Song, Wenbin Qian, Wenrong Huang, Zhenling Li, Yao Liu, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2024-204513
Published: 2024
Journal Articles

Efficacy and Safety of Zanubrutinib Monotherapy in Real-World Chinese CLL/SLL Patients

Shenmiao Yang, Huayuan Zhu, Ru Feng, Xutao Guo, Ting Niu, Jian-Qing Mi, Zhenling Li, Qianqian Ju, Liru Wang, Yujun Dong, Bingjie Wang, Liang Wang, Wanling Sun, Fang Fang, Liping Su, Yu Zhao, Xiaojun Huang, Jianyong Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6773.
https://doi.org/10.1182/blood-2024-206560
Published: 2024
Journal Articles

A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

Hua Jiang, Lu Li, Kaili Chen, Chunchen Yang, Ruixue Ma, Liangyu Xie, Can He, Fang Feng, Hao Wu, Xiaomei Chen, Dan Li, Xianghai Cai, Jin Zhao, Tao Guan, Li Ma, Min Bai, Guoxiang Wu, Liping Su, Weijun Fu
Journal: Blood
Blood (2024) 144 (Supplement 1): 923.
https://doi.org/10.1182/blood-2024-201160
Published: 2024
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study

Huixing Zhou, Long Chang, Jie Ma, Jingnan Sun, Hua Xue, Yanping Ma, Hongming Huang, Hebing Zhou, Liping Su, Zhenling Li, Hai Zhou, Wenrong Huang, Jun Luo, Jing Jia, Hongmei Jing, Guohong Su, Jihao Zhou, Biyun Chen, Guoxiang Zhang, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 1978.
https://doi.org/10.1182/blood-2024-201978
Published: 2024
Journal Articles

Phase 1/2 Studies of DZD8586, a Non-Covalent BBB Penetrant LYN/BTK Dual Inhibitor, in BTK Inhibitor Resistant Chronic Lymphocytic Leukemia (CLL) and Other B-Cell Non-Hodgkin Lymphoma (B-NHL)

Yuqin Song, Keshu Zhou, Hongmei Jing, Geoffrey Chong, Jianqiu Wu, Wei Liu, Zengjun Li, Ming Jiang, Mei Lan, Kaiyang Ding, Guohui CUI, Tingyu Wang, Xutao Guo, Sujun Gao, Constantine S. Tam, Haiyan Yang, Fang Zhu, Wei Yang, Jian-Qing Mi, Liping Su, Ke Fang, Ziyi Liu, Lindsey Roeker, Chan Y. Cheah, Jianyong Li, Lu-Gui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3248.
https://doi.org/10.1182/blood-2024-197877
Published: 2024
Journal Articles

Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)

Jie Jin, Qingqing Cai, Liling Zhang, Liqun Zou, Zengjun Li, Huijing Wu, Keshu Zhou, Lihua Qiu, Liping Su, Kaiyang Ding, Hui Zhou, Li Yu, Fei Li, Qing Xiao, Wenyu Li, Lie Lin, Erhua Wang, Lijia Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4430.
https://doi.org/10.1182/blood-2023-185543
Published: 2023
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Huixing Zhou, Long Chang, Jing Jia, Jie Ma, Hua Xue, Hao Li, Wenrong Huang, Hebing Zhou, Jingnan Sun, Liping Su, Yanping Ma, Huang Hongming, Hongmei Jing, Zhenling Li, Guangyu Ma, Guohong Su, Jihao Zhou, Biyun Chen, LI Bao, Zhihua Zhang, Lin Yang, Haiping Yang, Yanhong Zhao, Chunyan Sun, Qingming Wang, Qimuge Saiyin, Da Gao, Xiaoxia Chu, Zhenfang Xi, Weiwei Tian, Xuliang Shen, Shi Minxia, Jin Zhang, Yi Chen, Jingbo Xu, Yao Liu, Hongling Peng, Weijun Fu, Jun Luo, Zhenyu Li, Hui-Han Wang, Xiaobo Wang, Xiuli Sun, Jinqiao Zhang, Wei WANG, Yan Yan, Yafei Wang, Xin Du, Yonghuai Feng, Yi Wang, Ying Sun, Liye Zhong, Li Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2023-180736
Published: 2023
Journal Articles

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Jie Zha, Qinwei Chen, Wei Zhang, Hongmei Jing, Jingjing Ye, Haifeng Yu, Shuhua Yi, Caixia Li, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2023-182812
Published: 2023
Journal Articles

A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses

Huilai Zhang, Liping Su, Lihong Liu, Ou Bai, Zheng Song, Zhiqiang Zhao, Cuiying He, Qiang Guo, Xianhuo Wang, Wei Li, Lihua Qiu, Lanfang Li, Shiyong Zhou, Yue Fei, Xiaohui Wang, Bin Meng
Journal: Blood
Blood (2023) 142 (Supplement 1): 736.
https://doi.org/10.1182/blood-2023-178509
Published: 2023
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023
Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2023-174308
Published: 2023
Journal Articles

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Lu Zhang, Yujun Dong, Hongling Peng, Hao Li, Mingzhi Zhang, Hui-Han Wang, Qinhua Liu, Liping Su, Liye Zhong, Wenjun Wu, Liang Huang, Xiaojing Yan, Lei Fan, Wenjiao Tang, Zhenling Li, Lintao Bi, Yan Li, Guangxun Gao, Li Gao, Ting-Bo Liu, Yongqiang Wei, Yao Liu, Yu Li, Hui Zhou, Chunyan Sun, Wenbin Qian, Dehui Zou, Huilai Zhang, Kaiyang Ding, Xiaobo Wang, Ou Bai, Wenrong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shuye Wang, Liangming Ma, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 3609–3611.
https://doi.org/10.1182/blood-2022-158675
Published: 2022